This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
fin-tech: Archive
After Golden Cross, Invesco (IVZ)'s Technical Outlook is Bright
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
IVZNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
PYPL Stock Falls 10% Post Q2 Earnings: Should You Buy, Hold or Fold?
by Moumita C. Chattopadhyay
PayPal stock plunges 10% despite strong Q2 results and raised guidance, highlighting tension between progress and expectations.
PYPLNegative Net Change MANegative Net Change VNegative Net Change
artificial-intelligence fin-tech
Should You Buy Medpace (MEDP) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
MEDPNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Robinhood's Q2 Earnings Beat on Trading Surge & Higher NIR
by Zacks Equity Research
HOOD's Q2 earnings crush estimates as surging trading activity and higher net interest revenues fuel strong growth.
SCHWNegative Net Change IBKRNegative Net Change HOODNegative Net Change
earnings fin-tech finance
UBS Group Q2 Earnings & Revenues Rise Y/Y, Expenses Decline
by Zacks Equity Research
UBS posted a $2.39B Q2 profit, boosted by Wealth and Investment Bank gains, while costs fell and Credit Suisse integration advanced.
DBNegative Net Change UBSNegative Net Change IBNNegative Net Change
earnings fin-tech
PGY's Asset-Light Balance Sheet Model: Does it Offer a Safe Bet?
by Nikita Kataruka
Pagaya's asset-light model shields it from credit risk while powering 213% YTD gains and sharp earnings growth forecasts.
TREEPositive Net Change UPSTNegative Net Change PGYNegative Net Change
fin-tech finance
Visa Q3 Earnings Beat Estimates on Strong Cross-Border Volumes
by Zacks Equity Research
V posts 23% y/y EPS growth in Q3 and beats estimates, fueled by rising cross-border and processed transaction volumes.
VNegative Net Change COHRNegative Net Change TRUNegative Net Change APGNegative Net Change
business-services earnings fin-tech finance payments
TEMENOS GROUP (TMSNY)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
TMSNYNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
TransAlta (TAC) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
TACPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Prime Medicine, Inc. (PRME) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
PRMEPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Regions Financial (RF) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
RFNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Buy Visa Stock on Impressive Q2 Earnings and Strong Business Visibility
by Nalak Das
Visa posts strong Q2 earnings, expands in AI and stablecoins, and eyes long-term growth through digital payment innovation.
MANegative Net Change VNegative Net Change WUNegative Net Change PYPLNegative Net Change
fin-tech
StoneCo vs. Upstart: Which Fintech Stock Has More Upside This Year?
by Moumita C. Chattopadhyay
STNE and UPST are taking distinct fintech routes. One is scaling in Brazil, while the other is rewriting U.S. credit with AI. Which has more upside?
STNENegative Net Change UPSTNegative Net Change
artificial-intelligence fin-tech
Should You Buy AppFolio (APPF) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
APPFPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
F.N.B. (FNB)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
FNBNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Amgen (AMGN) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
AMGNPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Pagaya vs. OneMain: Which Consumer Credit Stock is a Smarter Bet?
by Nikita Kataruka
PGY leans on AI and asset-light growth, while OMF bets on brick-and-mortar lending and shareholder returns. Which stock deserves a place in your portfolio?
OMFNegative Net Change PGYNegative Net Change
banking fin-tech
Solid Transaction-Based Revenues to Drive HOOD's Q2 Earnings
by Zacks Equity Research
Robinhood's Q2 earnings are likely to have improved as trading volumes, crypto momentum and equity rise to fuel revenue growth.
SCHWNegative Net Change IBKRNegative Net Change HOODNegative Net Change
earnings fin-tech finance
Top Founder-Run Company Stocks That Are Outperforming the Market
by Tanuka De
Meta, Netflix, Robinhood Markets and DoorDash stand out as founder-run companies with strong vision, innovation, and long-term growth drivers.
NFLXNegative Net Change DASHNegative Net Change METANegative Net Change HOODNegative Net Change
consumer-discretionary cryptocurrency fin-tech internet
PayPal Q2 Earnings Preview: Should You Buy the Stock Now or Wait?
by Moumita C. Chattopadhyay
PayPal targets Q2 EPS of up to $1.31, with higher TPV and active accounts fueling modest revenue and margin growth.
PYPLNegative Net Change MANegative Net Change VNegative Net Change
earnings-preview fin-tech
Should You Buy Alphabet Inc. (GOOG) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
GOOGNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should Robinhood Shares Be in Your Portfolio Pre-Q2 Earnings?
by Swayta Shah
HOOD eyes strong Q2 growth with soaring trading revenues and user gains, but regulatory risks still loom large. Is the stock a buy ahead of Q2 earnings?
SCHWNegative Net Change IBKRNegative Net Change HOODNegative Net Change
earnings-preview fin-tech finance
Coinbase vs. Circle: Which Stablecoin Powerhouse Is a Safer Bet?
by Tanuka De
COIN's broader revenue streams and strategic U.S. focus may offer steadier returns than CRCL's stablecoin-centric model.
COINNegative Net Change CRCLNegative Net Change
cryptocurrency fin-tech finance
3 Momentum Anomaly Picks as Markets Hit Record High on the Trot
by Supriyo Bose
NFLX, HOOD and AFRM made the momentum cut with strong 1-year gains and brief pullbacks, flashing a potential entry point.
NFLXNegative Net Change AFRMNegative Net Change HOODNegative Net Change
artificial-intelligence consumer-discretionary fin-tech finance internet-content tech-stocks
Raymond James Financial, Inc. (RJF) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
RJFNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines